Gotowa bibliografia na temat „Thrombotic risk”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Thrombotic risk”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Thrombotic risk"
Cheng, Hai, Dian Zhou, Jiang Cao, Wei Chen, Kunming Qi, Kailin Xu i Jianlin Qiao. "A Study about the Relationship between Thrombotic Events and Peripheral Neutrophil-to-Lymphocyte Ratio in Patients with Newly Diagnosed Essential Thrombocythemia". Blood 132, Supplement 1 (29.11.2018): 5465. http://dx.doi.org/10.1182/blood-2018-99-112785.
Pełny tekst źródłaMancuso, Salvatrice, Vincenzo Accurso, Marco Santoro, Simona Raso, Angelo Davide Contrino, Alessandro Perez, Florinda Di Piazza, Ada Maria Florena, Antonio Russo i Sergio Siragusa. "The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors". Advances in Hematology 2020 (27.03.2020): 1–5. http://dx.doi.org/10.1155/2020/9124821.
Pełny tekst źródłaYamamoto, J., T. Taka, K. Yamada, Y. Ijiri, M. Murakami, Y. Hirata, A. Naemura i in. "Tomatoes have natural anti-thrombotic effects". British Journal of Nutrition 90, nr 6 (grudzień 2003): 1031–38. http://dx.doi.org/10.1079/bjn2003988.
Pełny tekst źródłaNavarro, Luana Magalhães, Damila Cristina Trufelli, Debora Rodrigues Bonito, Auro Del Giglio i Patricia Weinschenker Bollmann. "Application of prognostic score IPSET-thrombosis in patients with essential thrombocythemia of a Brazilian public service". Revista da Associação Médica Brasileira 62, nr 7 (październik 2016): 647–51. http://dx.doi.org/10.1590/1806-9282.62.07.647.
Pełny tekst źródłaChang, Simon, Christian Fynbo Christiansen, Anders Bojesen, Svend Juul, Anna-Marie B. Münster i Claus H. Gravholt. "Klinefelter syndrome and testosterone treatment: a national cohort study on thrombosis risk". Endocrine Connections 9, nr 1 (styczeń 2020): 34–43. http://dx.doi.org/10.1530/ec-19-0433.
Pełny tekst źródłaHenni, Samir, Pierre Ramondou, Guillaume Duval, Jean Picquet, Georges Leftheriotis i Pierre Abraham. "The risk of lower-limb superficial vein thrombosis relative to lower-limb venous thrombotic events is not increased in winter months". Phlebology: The Journal of Venous Disease 35, nr 7 (10.01.2020): 533–37. http://dx.doi.org/10.1177/0268355519896729.
Pełny tekst źródłaLim, Sunghee, Ji Yoon Lee, Seok Jin Kim i Won Seog Kim. "The International Prognostic Index Is a Better Predictor of Thrombotic Complications Than the Khorana Score for Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: Results of a Single Center Prospective Cohort Study". Blood 120, nr 21 (16.11.2012): 5095. http://dx.doi.org/10.1182/blood.v120.21.5095.5095.
Pełny tekst źródłaMiller, Mariel, Kamil K. Khanipov, Christopher Zahner i George K. Golovko. "Increased Risk of Thrombosis in Patients with Polycystic Ovarian Syndrome". Blood 142, Supplement 1 (28.11.2023): 5544. http://dx.doi.org/10.1182/blood-2023-190997.
Pełny tekst źródłaKreidy, Raghid. "Pathophysiology of Post-Thrombotic Syndrome: The Effect of Recurrent Venous Thrombosis and Inherited Thrombophilia". ISRN Vascular Medicine 2011 (9.11.2011): 1–4. http://dx.doi.org/10.5402/2011/513503.
Pełny tekst źródłaPark, D. J., S. E. Choi, H. Xu, J. H. Kang i S. S. Lee. "AB0442 RISK FACTORS ASSOCIATED WITH THROMBOTIC EVENTS IN KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS". Annals of the Rheumatic Diseases 79, Suppl 1 (czerwiec 2020): 1519.3–1520. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1674.
Pełny tekst źródłaRozprawy doktorskie na temat "Thrombotic risk"
De, Lange Margaretha Elisabeth. "A twin study of thrombotic aspects of insulin resistance syndrome : determination of genetic and environmental contribution to thrombotic risk". Thesis, King's College London (University of London), 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.406126.
Pełny tekst źródłaKhan, Abdullah Rubiat (Emon). "Microparticles and their role in thrombosis in Behçet's Syndrome and their potential as a biomarker for thrombotic risk". Thesis, Imperial College London, 2017. http://hdl.handle.net/10044/1/58996.
Pełny tekst źródłaSingh, Indu, i indu singh@rmit edu au. "The influence of antioxidants on thrombotic risk factors in healthy population". RMIT University. Medical Sciences, 2008. http://adt.lib.rmit.edu.au/adt/public/adt-VIT20081205.121719.
Pełny tekst źródłaSharma, Sumeet. "Thrombotic risk assessment in end stage renal disease patients on renal replacement therapy". Thesis, University of Hertfordshire, 2015. http://hdl.handle.net/2299/17114.
Pełny tekst źródłaWright, Joy Rhiannon. "Variation in the haemostatic response and thrombotic risk : interplay between haemostatic factors, platelets and monocytes". Thesis, University of Leicester, 2010. http://hdl.handle.net/2381/10075.
Pełny tekst źródłaWebster, Danielle L. M. D. "Higher Volume Hypertonic Saline and Increased Thrombotic Risk Without Improved Survival in Pediatric Traumatic Brain Injury". University of Cincinnati / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1406810346.
Pełny tekst źródłaKundur, Avinash Reddy. "An Investigation into Gilbert’s Syndrome: Understanding the Role of Unconjugated Bilirubin in Targeting Platelet and Haemostatic Mechanisms Associated with Thrombotic Risk Factors". Thesis, Griffith University, 2017. http://hdl.handle.net/10072/368189.
Pełny tekst źródłaThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medical Science
Griffith Health
Full Text
Björklund, Erik. "Early risk stratification, treatment and outcome in ST-elevation myocardial infarction /". Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6050.
Pełny tekst źródłaMooe, Thomas. "Left ventricular thrombus and stroke after acute myocardial infarction". Doctoral thesis, Umeå universitet, Medicin, 1997. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-100547.
Pełny tekst źródłaS. 1-84: sammanfattning, s. 85-136: 5 uppsatser
digitalisering@umu
Heijden, Jeroen Frank van der. "Risk factors for bleeding during treatment with anti-thrombotics". [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2004. http://dare.uva.nl/document/75796.
Pełny tekst źródłaKsiążki na temat "Thrombotic risk"
Morganroth, Joel, i E. Neil Moore, red. Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-1605-3.
Pełny tekst źródłaAutar, Atmaram. Nursing assessment of clients at risk of deep vein thrombosis (DVT): Developing the Autar DVT scale. Birmingham: University of Central England in Birmingham, 1994.
Znajdź pełny tekst źródłaAutar, A. R. Advancing clinical practice in the management of Deep Vein Thrombosis (DVT): Development, application and evaluation of the Autar DVT risk assessment scale. Leicester: De Montfort University, 2002.
Znajdź pełny tekst źródłaEric, Kasner Scott, i Gorelick Philip B, red. Prevention and treatment of ischemic stroke. Philadelphia: Butterworth-Heinemann, 2004.
Znajdź pełny tekst źródłaJørgen, Jespersen, Bertina Rogier M, Haverkate F. 1931-, European Concerted Action on Thrombosis and Disabilities (Committee) i Commission of the European Communities., red. ECAT assay procedures: A manual of laboratory techniques. Dordrecht: Kluwer Academic Publishers, 1992.
Znajdź pełny tekst źródłaJoel, Morganroth, i Moore E. Neil, red. Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988. Boston: Kluwer Academic Publishers, 1989.
Znajdź pełny tekst źródłaHendriks, Herman G. D., i Joost T. M. de Wolf. Haematological and coagulation disorders and anaesthesia. Redaktor Philip M. Hopkins. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199642045.003.0084.
Pełny tekst źródłaAlikhan, Raza. Prothrombotic conditions. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0285.
Pełny tekst źródłaProvan, Drew, Trevor Baglin, Inderjeet Dokal i Johannes de Vos. Haemostasis and thrombosis. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199683307.003.0010.
Pełny tekst źródłaProvan, Drew, Trevor Baglin, Inderjeet Dokal, Johannes de Vos i Angela Theodoulou. Haemostasis and thrombosis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199683307.003.0010_update_001.
Pełny tekst źródłaCzęści książek na temat "Thrombotic risk"
Price, Erika Leemann, i Tracy Minichiello. "Thrombotic Risk Factors". W The Coagulation Consult, 185–202. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-9560-4_12.
Pełny tekst źródłaSchindler, Adolf E. "Hormonal Contraceptives: Progestogen and Thrombotic Risk". W ISGE Series, 69–75. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-09662-9_8.
Pełny tekst źródłaAngelo Claudio, Molinari, i Paola Saracco. "The Thrombotic Risk of the Newborn". W Neonatology, 1–15. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-18159-2_239-1.
Pełny tekst źródłaClaudio, Molinari Angelo, i Paola Saracco. "The Thrombotic Risk of the Newborn". W Neonatology, 1455–69. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-29489-6_239.
Pełny tekst źródłaMariani, G., G. D. Di Nucci, A. Chistolini, M. Motta i F. Mandelli. "On the Evaluation of the Thrombotic Risk". W Advances in Hemostasis and Thrombosis, 129–40. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4615-9424-6_13.
Pełny tekst źródłaDebbie Jiang, M. D., i M. D. Alfred Ian Lee. "Thrombotic Risk from Chemotherapy and Other Cancer Therapies". W Thrombosis and Hemostasis in Cancer, 87–101. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-20315-3_6.
Pełny tekst źródłaMammen, Eberhard F. "Oral Contraceptives and Thrombotic Risk: A Critical Overview". W Sex Steroids and the Cardiovascular System, 65–93. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-662-02764-6_5.
Pełny tekst źródłaEsplugas, E. "Contrast media effect of thrombotic risk during coronary angioplasty". W Abrupt closure during coronary angioplasty, 35–40. Paris: Springer Paris, 1991. http://dx.doi.org/10.1007/978-2-8178-0877-2_5.
Pełny tekst źródłaSiegemund, A., T. Siegemund, U. Scholz, S. Petros i L. Engelmann. "Different Thrombotic Risk Factors — Contribution to the Endogenous Thrombin Potential". W 33rd Hemophilia Symposium, 257–61. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-642-18260-0_41.
Pełny tekst źródłaCianciaruso, B., G. di Minno, P. Ames, V. Bellizzi i G. Bovi. "Thrombotic Risk During r-EPO Therapy in Hemodialyzed Patients. A New Hypothesys". W New Therapeutic Strategies in Nephrology, 349–51. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3884-4_102.
Pełny tekst źródłaStreszczenia konferencji na temat "Thrombotic risk"
Broekmans, A. W., F. J. M. der Meer i K. Briët. "TREATMENT OF CONGENITAL THROMBOTIC SYNDROMES". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643718.
Pełny tekst źródłaRouvier, J., H. Vidal, J. Gallino, M. Boccia, A. Scazziota i R. Altman. "ACUTE INTERRUPTION OF ORAL ANTICOAGULANT THERAPY: A THROMBOTIC RISK?" W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643265.
Pełny tekst źródłaHill, Samuel J., Alistair Young, Ronak Rajani i Adelaide De Vecchi. "Assessment of Thrombotic Risk following Transcatheter Mitral Valve Replacement". W 2021 Computing in Cardiology (CinC). IEEE, 2021. http://dx.doi.org/10.23919/cinc53138.2021.9662855.
Pełny tekst źródłaBertaggia, D., A. Aliotta i L. Alberio. "A New Laboratory Tool to Detect Hypercoagulation and Thrombotic Risk". W 63rd Annual Meeting of the Society of Thrombosis and Haemostasis Research. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680254.
Pełny tekst źródłaWilson, J., P. J. Grant, M. Boothby, J. A. Davis i C. R. M. Prentice. "ENDOGENOUS VASOPRESSIN RELEASE CONTRIBUTES TO THE THROMBOTIC RISK OF HIP SURGERY". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643695.
Pełny tekst źródłaSchwartz, R., E. Kavanagh, K. Bauer, R. Rosenberg, J. Ballard, J. Latino, V. Strother, M. Mosesson, W. Haire i M. DeLeo. "ANTITHROMBIN III CONCENTRATE (AT-III) FOR PROPHYLAXIS ANDTREATMENT OF CONGENITAL AND ACQUIREDAT-III DEFCIENCY". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643678.
Pełny tekst źródłaBorrell, M., J. Fontcuberta, E. Muñiz, E. Grau i A. Oliver. "FIBRINOLYTIC ACTIVITY AND OTHER COAGULATION PROTEINS IN PATIENTS WITH LUPUS ANTICOAGULANT". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644237.
Pełny tekst źródłaKonig, Maximillian F., Jessica Li i Michelle Petri. "O1 Hydroxychloroquine blood levels and risk of thrombotic events in systemic lupus erythematous". W 12th European Lupus Meeting. Lupus Foundation of America, 2020. http://dx.doi.org/10.1136/lupus-2020-eurolupus.15.
Pełny tekst źródłaFinke, U., J. Schneider, E. Friderichs, L. Flohé i H. Giertz. "MYOCARDIAL SALVAGE BY COMBINED TREATMENT WITH RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN ACTIVATOR AND RECOMBINANT HUMAN SUPEROXIDE DISMUTASE IN A CANINE CORONARY THROMBOSIS MODEL*". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643570.
Pełny tekst źródłaDautzenberg, M. D., F. Monge, A. M. Fischer, R. Girot i P. Cornu. "COAGULATION AND FIBRINOLYSIS IN SICKLE CELL DISEASE". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643056.
Pełny tekst źródłaRaporty organizacyjne na temat "Thrombotic risk"
Chan, Benjamin, Ayodele Odutayo, Peter Juni, Nathan M. Stall, Pavlos Bobos, Adalsteinn D. Brown, Allan Grill i in. Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID-19 Vaccines. Ontario COVID-19 Science Advisory Table, maj 2021. http://dx.doi.org/10.47326/ocsat.2021.02.28.1.0.
Pełny tekst źródłaShi, Guoxin, i Wen Zhao. Risk factors for deep venous thrombosis in patients with stroke: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2022. http://dx.doi.org/10.37766/inplasy2022.5.0045.
Pełny tekst źródłaXiong, Yuchen, Weiwei Wu i Shanzi Yu. Different spine tumor pathology and risk of venous thrombosis : systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, marzec 2023. http://dx.doi.org/10.37766/inplasy2023.3.0121.
Pełny tekst źródłaCheng, Fangqun, Biyun Ye, Ying Tang, Zhuo Xiao, Dan Liu, Ke Wang, Peiyu Cheng i Jingping Zhang. Risk factors for deep vein thrombosis in patients with cerebral hemorrhage: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, marzec 2022. http://dx.doi.org/10.37766/inplasy2022.3.0068.
Pełny tekst źródłahou, xianbing, dandan chen, tongfei cheng, dan wang, xiaojun dai, yao wang, bixian cui i in. Bleeding risk of anticoagulant therapy in patients with advanced cancer in palliative care settings:a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, kwiecień 2022. http://dx.doi.org/10.37766/inplasy2022.4.0064.
Pełny tekst źródłaGong, Wei, Yongqi Li, Yu Tian, Jing Zhang i Lei Li. Effects of cardiovascular disease and traditional cardiovascular risk factors on deep vein thrombosis in stroke patients: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, wrzesień 2022. http://dx.doi.org/10.37766/inplasy2022.9.0016.
Pełny tekst źródłaSaldanha, Ian J., Wangnan Cao, Justin M. Broyles, Gaelen P. Adam, Monika Reddy Bhuma, Shivani Mehta, Laura S. Dominici, Andrea L. Pusic i Ethan M. Balk. Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis. Agency for Healthcare Research and Quality (AHRQ), lipiec 2021. http://dx.doi.org/10.23970/ahrqepccer245.
Pełny tekst źródłaSignificant risk of another thrombosis remains if anticoagulation is stopped. National Institute for Health Research, październik 2019. http://dx.doi.org/10.3310/signal-000830.
Pełny tekst źródłaContinuing an anticoagulant at home after abdominal surgery cuts thrombosis risk. National Institute for Health Research, grudzień 2019. http://dx.doi.org/10.3310/signal-000850.
Pełny tekst źródła